Giant prolactinomas: are they really different from ordinary macroprolactinomas?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Giant prolactinomas: are they really different from ordinary macroprolactinomas?

Published:2015-11-11 Issue:3 Volume:52 Page:652-659
ISSN:1355-008X
Container-title:Endocrine
language:en
Short-container-title:Endocrine

Author:

Espinosa Etual,Sosa Ernesto,Mendoza Victoria,Ramírez Claudia,Melgar Virgilio,Mercado Moisés

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1007/s12020-015-0791-7.pdf

Reference21 articles.

1. A. Glezer, M. Bronstein, Prolactinomas. Endocrinol. Metab. Clin. North Am. 44, 71–78 (2015)

2. D. Maiter, E. Delgrange, Therapy of endocrine disease: the challenges in managing giant prolactinomas. Eur. J. Endocrinol. 170, R213–R227 (2014)

3. A.B. Moraes, C.S. Marques dos Santos, N.L. Vieira, M.R. Gadelha, Giant prolactinomas: the therapeutic approach. Clin. Endocrinol. (Oxf) 79, 447–456 (2013)

4. R. Shrivastava, M. Argenteanu, W. King, K. Post, Giant prolactinomas: clinical management and long-term follow up. J. Neurosurg. 97, 299–306 (2002)

5. M. Corsello, G. Ubertini, M. Altomare, R. Lovicu, M. Migneco, C. Rota, C. Colosimo, Giant prolactinomas in men: efficacy of cabergoline treatment. Clin. Endocrinol. (Oxf) 58, 662–670 (2003)

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Visual morbidity in macroprolactinoma: A retrospective cohort study;Clinical Endocrinology;2024-08-18

2. Prolactin-secreting pituitary adenomas: male-specific differences in pathogenesis, clinical presentation and treatment;Frontiers in Endocrinology;2024-02-02

3. Prolactinomas Resistant to Dopamine Agonists: Pathophysiology and Treatment;Archives of Medical Research;2023-12

4. Long-term Discontinuation of Dopamine Agonist Treatment in Patients with Prolactinomas Revisited;Archives of Medical Research;2023-12

5. Giant prolactinoma in Asian-Indians: A single-center experience from Western India;Annales d'Endocrinologie;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3